TY - JOUR
T1 - Association between radiographic hand osteoarthritis and RANKL, OPG and inflammatory markers
AU - Pantsulaia, I.
AU - Kalichman, L.
AU - Kobyliansky, E.
N1 - Funding Information:
We are grateful to Dr Ida Malkin for her help in statistical analysis. This study was supported by a grant from the Israeli National Science Foundation – “Academia”, no. 1042-04 and the Hirsch and Genia Wasserman Memorial Fund for medical research. The authors wish to thank Mrs Phyllis Curchack Kornspan for her editorial services.
PY - 2010/11/1
Y1 - 2010/11/1
N2 - Objective: The aim of the study was to evaluate the association between prevalence and severity of radiographic hand osteoarthritis (OA) and serum levels of systemic inflammatory markers in a community-based population sample. Design: A cross-sectional observational study was conducted on a population comprised 1452 Chuvashians (763 males, aged 49.23±17.43; and 689 females, aged 50.37±17.47 years). OA was evaluated in 14 joints of each hand using Kellgren and Lawrence (K-L), joint space narrowing (JSN) and osteophyte (OS) scores. Serum levels of systemic inflammatory and osteoclastogenic cytokines were measured by an enzyme-linked immunosorbent assay (ELISA). Statistical analyses included descriptive statistics, correlation analysis and multiple linear regressions. Results: Monocyte chemotactic protein-1 (MCP-1) and osteoprotegerin (OPG) levels were associated with OA traits, but the statistically significant correlations were weak and/or moderate. In particular, the MCP-1 inflammation marker showed a statistically significant association with JSN (β= 0.077, P= 0.022) and OS (β= 0.067, P= 0.024) scores, but not with the number of affected joints (K-L≥2). OPG was significantly correlated with the scores as to the number of affected joints (β= 0.063, P= 0.035) and OS (β= 0.077, P= 0.028). No significant associations were found between levels of other inflammatory [interleukin (IL)-6, tumor necrosis factor (TNF)-α, IL-17] and osteoclastogenic [receptor activator for nuclear factor κ B ligand (RANKL), macrophage colony-stimulating factor (M-CSF)] cytokines and OA characteristics. Conclusions: This study strengthens the premise that OPG might be a valid biomarker of hand OA. Confirmation of these results in larger cohorts of patients will reinforce our theory that the RANKL/OPG pathway is a suitable target for developing novel agents against OA.
AB - Objective: The aim of the study was to evaluate the association between prevalence and severity of radiographic hand osteoarthritis (OA) and serum levels of systemic inflammatory markers in a community-based population sample. Design: A cross-sectional observational study was conducted on a population comprised 1452 Chuvashians (763 males, aged 49.23±17.43; and 689 females, aged 50.37±17.47 years). OA was evaluated in 14 joints of each hand using Kellgren and Lawrence (K-L), joint space narrowing (JSN) and osteophyte (OS) scores. Serum levels of systemic inflammatory and osteoclastogenic cytokines were measured by an enzyme-linked immunosorbent assay (ELISA). Statistical analyses included descriptive statistics, correlation analysis and multiple linear regressions. Results: Monocyte chemotactic protein-1 (MCP-1) and osteoprotegerin (OPG) levels were associated with OA traits, but the statistically significant correlations were weak and/or moderate. In particular, the MCP-1 inflammation marker showed a statistically significant association with JSN (β= 0.077, P= 0.022) and OS (β= 0.067, P= 0.024) scores, but not with the number of affected joints (K-L≥2). OPG was significantly correlated with the scores as to the number of affected joints (β= 0.063, P= 0.035) and OS (β= 0.077, P= 0.028). No significant associations were found between levels of other inflammatory [interleukin (IL)-6, tumor necrosis factor (TNF)-α, IL-17] and osteoclastogenic [receptor activator for nuclear factor κ B ligand (RANKL), macrophage colony-stimulating factor (M-CSF)] cytokines and OA characteristics. Conclusions: This study strengthens the premise that OPG might be a valid biomarker of hand OA. Confirmation of these results in larger cohorts of patients will reinforce our theory that the RANKL/OPG pathway is a suitable target for developing novel agents against OA.
KW - Hands
KW - Inflammation markers
KW - Osteoarthritis
UR - http://www.scopus.com/inward/record.url?scp=78149410924&partnerID=8YFLogxK
U2 - 10.1016/j.joca.2010.06.009
DO - 10.1016/j.joca.2010.06.009
M3 - Article
C2 - 20633673
AN - SCOPUS:78149410924
SN - 1063-4584
VL - 18
SP - 1448
EP - 1453
JO - Osteoarthritis and Cartilage
JF - Osteoarthritis and Cartilage
IS - 11
ER -